Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00688948
Recruitment Status : Terminated (Lack of funding)
First Posted : June 3, 2008
Last Update Posted : June 27, 2011
Information provided by:
Nova Scotia Health Authority

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2009
  Actual Study Completion Date : November 2009